title: [Application of AT1-angiotensin II receptor blocker valsartan in clinical practice].
authors.forename: M L
authors.initials: ML
authors.lastname: Maksimov
authors.forename: I A
authors.initials: IA
authors.lastname: Mochkin
authors.forename: A K
authors.initials: AK
authors.lastname: Starodubtsev
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects; D016903:Drug Monitoring; D006333:Heart Failure / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000378:metabolism; D016032:Randomized Controlled Trials as Topic; D011945:Receptors, Angiotensin / Q000378:metabolism*; D051437:Renal Insufficiency / Q000188:drug therapy* / Q000378:metabolism; D012084:Renin-Angiotensin System / Q000187:drug effects; D013777:Tetrazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism; D014633:Valine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000378:metabolism; D000068756:Valsartan; D014882:Water-Electrolyte Balance / Q000187:drug effects
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D011945:Receptors, Angiotensin; D013777:Tetrazoles; D000068756:Valsartan; D014633:Valine